Michael L. Hall

Nessuna posizione attualmente

62 anni

Health Technology

Consumer Services

Profilo

Michael L.
Hall served as Chief Medical Officer & SVP-Regulatory Affairs at Repligen Corp.
in 2011, Senior Vice President-Clinical Development at Ironwood Pharmaceuticals, Inc., Chief Medical Affairs at Novartis Pharmaceuticals Corp., and Vice President at Shire Human Genetic Therapies, Inc. He holds a doctorate degree from the University of the Witwatersrand.

Precedenti posizioni note di Michael L. Hall

Società	Posizione	Fine
Novartis Pharmaceuticals Corp. Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ.	Direttore Tecnico/Scientifico/R&S	-
IRONWOOD PHARMACEUTICALS, INC.	Direttore Tecnico/Scientifico/R&S	-
Shire Human Genetic Therapies, Inc. Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Shire Human Genetic Therapies, Inc. develops medicines for the treatment of genetic diseases. The company was founded on July 7, 1988 and is headquartered in Lexington, MA.	Corporate Officer/Principal	-
REPLIGEN CORPORATION	Direttore Tecnico/Scientifico/R&S	-

Vedi nel dettaglio l'esperienza di Michael L. Hall

Formazione di Michael L. Hall

University of the Witwatersrand

Doctorate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private